Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult and pediatric patients.

As always, federal employees and annuitants should carefully review their plan options this fall to ensure their FEHB plan continues to meet their needs.

Medicare can be a complicated subject—especially when you dive into all its variations. “A lot of people hear ‘Part A,’ ‘Part ...